Search research articles
Contact Us
Filters
Showing results (81-90 of 183) with videos related to
Page
of 19
Sort By:
Frontiers in Oncology
|
June 10, 2021
Post-Biopsy Cell-Free DNA From Blood: An Open Window on Primary Prostate Cancer Genetics and Biology
Marinella Corbetta, Chiara Chiereghin, Ilaria De Simone, et al.
Journal of Clinical Medicine
|
August 10, 2024
The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature
Francesco Claps, Arianna Biasatti, Luca Di Gianfrancesco, et al.
European Urology Oncology
|
August 5, 2023
En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial
David D'Andrea, Francesco Soria, Rodolfo Hurle, et al.
Minerva Urology and Nephrology
|
May 31, 2024
Impact of a structured rehabilitation program on urinary continence in patients with intermediate high-risk prostate cancer undergoing robotic-assisted laparoscopic prostatectomy
Pier P Avolio, Vittorio Fasulo, Giovanni Lughezzani, et al.
Urologic Oncology
|
February 29, 2024
Development of a microultrasound-based nomogram to predict extra-prostatic extension in patients with prostate cancer undergoing robot-assisted radical prostatectomy
Nicola Frego, Roberto Contieri, Vittorio Fasulo, et al.
European Urology Oncology
|
November 17, 2023
Reply to Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol 2023;6:508-15
David D'Andrea, Francesco Soria, Rodolfo Hurle, et al.
Urologia Internationalis
|
February 1, 2023
Diagnostic Performance and Clinical Impact of PSMA PET/CT versus mpMRI in Patients with a High Suspicion of Prostate Cancer and Previously Negative Biopsy: A Prospective Trial (PROSPET-BX)
Egesta Lopci, Massimo Lazzeri, Piergiuseppe Colombo, et al.
Nutrients
|
June 19, 2024
Nutritional Prehabilitation in Patients Undergoing Cystectomy: A Systematic Review
Susy Dal Bello, Stefano Mancin, Sara Morales Palomares, et al.
European Urology Oncology
|
October 21, 2023
Reply to Riccardo Lombardo, Sara Riolo, and Cosimo De Nunzio's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. 2023;6:508-515
David D'Andrea, Francesco Soria, Rodolfo Hurle, et al.
Urologic Oncology
|
July 27, 2024
Clinically significant prostate cancer detection rate in biopsy-naïve patients with mpMRI and microultrasound topographically discordant lesions: A single-center retrospective analysis
Filippo Dagnino, Pier Paolo Avolio, Vittorio Fasulo, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 183) with videos related to
Sort By:
Page
of 19
Frontiers in Oncology
|
June 10, 2021
Post-Biopsy Cell-Free DNA From Blood: An Open Window on Primary Prostate Cancer Genetics and Biology
Marinella Corbetta, Chiara Chiereghin, Ilaria De Simone, et al.
Journal of Clinical Medicine
|
August 10, 2024
The Prognostic Significance of Histological Subtypes in Patients with Muscle-Invasive Bladder Cancer: An Overview of the Current Literature
Francesco Claps, Arianna Biasatti, Luca Di Gianfrancesco, et al.
European Urology Oncology
|
August 5, 2023
En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial
David D'Andrea, Francesco Soria, Rodolfo Hurle, et al.
Minerva Urology and Nephrology
|
May 31, 2024
Impact of a structured rehabilitation program on urinary continence in patients with intermediate high-risk prostate cancer undergoing robotic-assisted laparoscopic prostatectomy
Pier P Avolio, Vittorio Fasulo, Giovanni Lughezzani, et al.
Urologic Oncology
|
February 29, 2024
Development of a microultrasound-based nomogram to predict extra-prostatic extension in patients with prostate cancer undergoing robot-assisted radical prostatectomy
Nicola Frego, Roberto Contieri, Vittorio Fasulo, et al.
European Urology Oncology
|
November 17, 2023
Reply to Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol 2023;6:508-15
David D'Andrea, Francesco Soria, Rodolfo Hurle, et al.
Urologia Internationalis
|
February 1, 2023
Diagnostic Performance and Clinical Impact of PSMA PET/CT versus mpMRI in Patients with a High Suspicion of Prostate Cancer and Previously Negative Biopsy: A Prospective Trial (PROSPET-BX)
Egesta Lopci, Massimo Lazzeri, Piergiuseppe Colombo, et al.
Nutrients
|
June 19, 2024
Nutritional Prehabilitation in Patients Undergoing Cystectomy: A Systematic Review
Susy Dal Bello, Stefano Mancin, Sara Morales Palomares, et al.
European Urology Oncology
|
October 21, 2023
Reply to Riccardo Lombardo, Sara Riolo, and Cosimo De Nunzio's Letter to the Editor re: David D'Andrea, Francesco Soria, Rodolfo Hurle, et al. En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): A Prospective, Multicenter, Open-label, Phase 3 Randomized Controlled Trial. Eur Urol Oncol. 2023;6:508-515
David D'Andrea, Francesco Soria, Rodolfo Hurle, et al.
Urologic Oncology
|
July 27, 2024
Clinically significant prostate cancer detection rate in biopsy-naïve patients with mpMRI and microultrasound topographically discordant lesions: A single-center retrospective analysis
Filippo Dagnino, Pier Paolo Avolio, Vittorio Fasulo, et al.
Page
of 19